✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Bharat Parenterals Ltd.

BPLPHARMA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹638 Cr.
P/E
0.00

Bharat Parenterals Ltd.

  • Bharat Parenterals
  • Kilitch Drugs(India)
  • Prevest Denpro
  • TJI Pharma - Small Cap

FAQs on Bharat Parenterals Ltd. Shareprice

Bharat Parenterals has given better returns compared to its competitors.
Bharat Parenterals has grown at ~20.47% over the last 4yrs while peers have grown at a median rate of 8.45%

Bharat Parenterals is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Bharat Parenterals is 36.26, while 3 year average PE is 17.83.
Also latest EV/EBITDA of Bharat Parenterals is 39.25 while 3yr average is 87.81.

View FAQ's On Business

Growth Table

  • Bharat Parenterals Ltd.
  • Kilitch Drugs(India)
  • Prevest Denpro

Balance Sheet

  • Bharat Parenterals Ltd.
  • Kilitch Drugs(India)
  • Prevest Denpro

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Bharat Parenterals Ltd.
  • Kilitch Drugs(India)
  • Prevest Denpro

Cash Flow

  • Bharat Parenterals Ltd.
  • Kilitch Drugs(India)
  • Prevest Denpro

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Bharat Parenterals Ltd.
  • Kilitch Drugs(India)
  • Prevest Denpro

Quarterly Results

  • Bharat Parenterals Ltd.
  • Kilitch Drugs(India)
  • Prevest Denpro

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Bharat Parenterals Ltd. Financials

Balance sheet of Bharat Parenterals is moderately strong.

Yes, The net debt of Bharat Parenterals is increasing.
Latest net debt of Bharat Parenterals is ₹116 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹65.06 Crs.

No, profit is decreasing.
The profit of Bharat Parenterals is -₹28.58 Crs for TTM, -₹12.63 Crs for Mar 2025 and ₹14.52 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bharat Parenterals latest dividend payout ratio is 4.01% and 3yr average dividend payout ratio is 3.32%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech